Found 0 matching trials
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) PHASE2 The goal of this clinical study is to test how well the study drug, brexuca...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma PHASE1 The primary objectives of this study are:
Phase 1: To evaluate the safety ...
Show More Location
Stanford Cancer Institute
Learn More & Join Trial
T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma PHASE1 This is a single-center, open-label, single-arm study to evaluate the safet...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Maximizing Outcome of Multiple Sclerosis Transplantation PHASE3 Randomized study of autologous un-manipulated peripheral blood hematopoieti...
Show More Location
Northwestern University
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 PHASE1 Patients with recurrent or refractory neuroblastoma are resistance to conve...
Show More Status
Active Not Recruiting
Location
Seattle Children's Hospital
Learn More & Join Trial
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer PHASE1 Chimeric antigen receptor T cells (CAR-T) therapy has not yet been fully ex...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma PHASE3 The purpose of this study is to evaluate the efficacy and safety of sugemal...
Show More Location
Multiple Locations
Learn More & Join Trial
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma PHASE2 The purpose of this trial is to develop an alternative treatment for patien...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of the study is to characterize safety of JNJ-68284528 and esta...
Show More Location
Mayo Clinic Cancer Center-Scottsdale
Learn More & Join Trial